Journal of Pediatric and Adolescent Gynecology
Volume 21, Issue 5 , Pages 269-273 , October 2008

Hormonal Contraception and Blood Lead Levels in Inner-City Adolescent Girls

References 

  1. Centers for Disease Control and Prevention. Preventing lead poisoning in young children. Atlanta, GA: US Dept. of Health and Human Services, Centers for Disease Control and Prevention; 1991;
  2. Rogan WJ, Ware JH. Exposure to lead in children—how low is low enough?. N Eng J Med. 2003;348:1515
  3. Lanphear BP, Dietrich K, Auinger P, et al. Cognitive deficits associated with blood lead concentrations <10ug/dL in US children and adolescents. Public Health Reports. 2000;115:521
  4. Nordin J, Rolnick S, Ehlinger E, et al. Lead levels in high-risk and low young children in the Minneapolis-St. Paul metropolitan area. Pediatrics. 1998;101:72
  5. Rosen JF, Crocetti AF, Balbi K, et al. Bone lead content assessed by L-line x-ray fluorescence in lead-exposed and non-lead-exposed suburban populations in the United Stated. Proc Natl Acad Sci. 1993;90:2789
  6. Hoppin JA, Aro A, Hu H, et al. In vivo bone lead measurement in suburban teenagers. Pediatrics. 1997;100:365
  7. Silbergeld EK, Schwartz J, Mahaffey K. Lead and osteoporosis: mobilization of lead from bone in post-menopausal women. Environ Res. 1988;47:49
  8. Busen NH, Britt RB, Rianon N. Bone mineral density in a cohort of adolescent women using depot medroxyprogesterone acetate for one to two years. J Adolesc Health. 2003;32:257
  9. Cundy T, Evans M, Roberts H, et al. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ. 1991;303:13
  10. Cundy T, Cornish J, Evans MC, et al. Recovery of bone density in women who stop using medroxyprogesterone acetate. BMJ. 1993;308:247
  11. Scholes D, LaCroix AZ, Ichikawa LE, et al. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002;13:581
  12. Scholes D, LaCroix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med. 2005;159:139
  13. Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health. 2004;35:434
  14. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depo medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr. 1996;129:671
  15. Scholes D, Lacroix AZ, Ott SM, et al. Bone mineral density in women using depo-medroxyprogesterone acetate for contraception. Obstet Gynecol. 1999;93:233
  16. Lara-Torre E, Edwards CP, Perlman S, et al. Bone mineral density in adolescent females using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol. 2004;17:17
  17. Paiva LC, Pinto-Neto AM, Faundes A. Bone density among long term users of medroxyprogesterone acetate as a contraceptive. Contraception. 1998;58:351
  18. Tellez-Rojo MM, Hernandez-Avila M, Lamadrid-Figueroa H, et al. Impact of bone lead and bone resorption on plasma and whole blood lead levels during pregnancy. Am J Epidemiol. 2004;160:668
  19. Gulson BL, Mizon Palmer JM, et al. Blood lead changes during pregnancy and postpartum with calcium supplementation. Environ Health Perspect. 2004;112:1499
  20. Needleman HL, Gatsonis CA. Low level lead exposure and the IQ of children. JAMA. 1990;263:673
  21. Wright RO, Shannon MW, Wright RJ, et al. Association between iron deficiency and low-level lead poisoning in an urban primary care clinic. Am J Public Health. 1999;89:1049
  22. Canfield RL, Henderson CR, Cory-Slechta DA, et al. Intellectual impairment in children with blood lead concentrations below 10ug per deciliter. N Engl J Med. 2003;348:1517
  23. Davis DW, Chang F, Burns B, et al. Lead exposure and attention regulation in children living in poverty. Dev Med Child Neurol. 2004;46:825
  24. Moss ME, Lanphear BP, Auinger P. Association of dental caries and blood lead levels. JAMA. 1999;281:2294
  25. Mendelsohn AL, Dreyer BP, Fierman AH, et al. Low-level lead exposure and cognitive development in early childhood. Developmental and Behavioral Pediatrics. 1999;20:425
  26. Selevan SG, Rice DC, Hogan KA, et al. Blood lead concentration and puberty in girls. N Engl J Med. 2003;348:1527
  27. Markowitz ME, Grundberg CM, Rosen JF. Serum osteocalcin (Oc) is a new marker of childhood lead toxicity: Pb inhibits Oc binding to hydroxyapatite in vitro. Pediatr Res. 1986;20:332A
  28. Pounds JG, Rosen JF. Cellular metabolism of lead: A kenetic analysis in cultured osteoclastic bone cells. Toxicol Appl Pharmacol. 1986;83:531

PII: S1083-3188(08)00188-5

doi: 10.1016/j.jpag.2008.05.006

Journal of Pediatric and Adolescent Gynecology
Volume 21, Issue 5 , Pages 269-273 , October 2008

Article Tools